Skip to content

Comparison of the effect of corticosteroid injection, physiotherapy and combination therapy in frozen shoulder

Comparison of the effect of corticosteroid injection, physiotherapy and combination therapy in frozen shoulder

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT138802011828N1
Enrollment
105
Registered
2009-07-15
Start date
2009-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frozen shoulder. Adhesive capsulitis of shoulder

Interventions

Intervention 1: In corticosteroid group: 20 mg triamcinolone +1.5 cc lidocaine 2% in Subacromial bursa and 40 mg triamcinolone+ 3cc lidocaine 2% in shoulder joint with posterior approach by rheumatolo
Treatment - Drugs
Treatment - Devices
In corticosteroid group: 20 mg triamcinolone +1.5 cc lidocaine 2% in Subacromial bursa and 40 mg triamcinolone+ 3cc lidocaine 2% in shoulder joint with posterior approach by rheumatologist
In physiotherapy group: 10 sessions shoulder physiotherapy by a physiotherapist for 2 weeks
In third group: 20 mg triamcinolone +1.5 cc lidocaine 2% in Subacromial bursa and 40 mg triamcinolone+ 3cc lidocaine 2% in shoulder joint with posterior approach by rheumatologist after one week 10 se

Sponsors

Mazandaran University of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with adhesive capsulitis for less than one year, the age over18, total score 30 for SPADI Exclusion criteria: Patients with frozen shoulder accompanied with inflammation, degenerative, metabolic (except diabetes), infectious disorders, CVA or fracture or who had received steroid injection or physiotherapy during 6 month ago.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: before intervention and 6 and 24 weeks after intervention. Method of measurement: VAS.;Disability. Timepoint: before intervention and 6 and 24 weeks after intervention. Method of measurement: SPADI questionarie.

Secondary

MeasureTime frame
Passive flexion. Timepoint: before intervention and 6,24 weeks after intervention. Method of measurement: Goniometer.;Passive abdaction. Timepoint: before intervention and 6,24 weeks after intervention. Method of measurement: Goniometer.;Passive external rotation. Timepoint: before intervention and 6,24 weeks after intervention. Method of measurement: Goniometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMotahareh Kheradmand

Mazandaran Univercity of medical sciences and Health services

elhamkheradmand2003@yahoo.com; kheradmnd@mazums.ac.ir+98 15132612458

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026